Track Record

Transactions

The team has completed over 300 transactions and engagements for its clients — valued at over $35 billion — as Bookrunner, Co-Manager, Lead Placement Agent, Co-Placement Agent or Advisor.

Featured Transactions

April 2025Alcyone TherapeuticsBrookline served as Exclusive Placement Agent for the Series F Convertible Preferred stock offering.
September 2025Sale to BiogenBiogen acquired Alcyone Therapeutics in 2025. Brookline served as Alcyone's financial advisor.
July 2026Neela TherapeuticsNeela Therapeutics was spun out of the acquisition and Brookline served as the Exclusive Placement Agent for a Convertible Note in 2026.

Selected Client Transactions

Atreca
$35,000,000
Series B Convertible Preferred StockSole Placement Agent
August 2017
Q BioMed
$3,000,000
PIPESole Placement Agent
August 2017
Alzheon
$5,300,000
Series B Convertible Preferred StockSole Placement Agent
May 2017
Centrexion Therapeutics
$5,000,000
Convertible NoteSole Placement Agent
May 2017
Scynexis
$13,300,000
PIPECo-Placement Agent
May 2017
Valeritas
$52,500,000
IPOFinancial Advisor
March 2017
Applied Therapeutics
$7,000,000
Series A Convertible Preferred StockSole Placement Agent
February 2017
Aspira Women’s Health
$5,600,000
PIPECo-Placement Agent
February 2017
AnaBios
$8,000,000
Series B Convertible Preferred StockSole Placement Agent
December 2016
ATEA Pharmaceuticals
$23,000,000
Series B Convertible Preferred StockCo-Placement Agent
November 2016
Scynexis
$6,000,000
PIPESole Placement Agent
August 2016
ContraFect
$35,000,000
PIPEFinancial Advisor
July 2016
Rezolute
$12,000,000
PIPECo-Placement Agent
June 2016
CareDx
$22,000,000
PIPECo-Placement Agent
April 2016
Alzheon
$3,100,000
Convertible Sub NoteSole Placement Agent
February 2016
Scynexis
$5,300,000
PIPESole Placement Agent
December 2015
Atreca
$56,000,000
Series A Convertible Preferred StockSole Placement Agent
October 2015
Alzheon
$6,900,000
Convertible Sub NoteSole Placement Agent
July 2015
ContraFect
$20,000,000
PIPECo-Placement Agent
June 2015
Alzheon
$10,000,000
Series A Convertible Preferred StockSole Placement Agent
March 2015
Scynexis
$10,000,000
PIPESole Placement Agent
December 2014
Axsome Therapeutics
$4,000,000
Convertible NoteSole Placement Agent
November 2014
TRACON Pharmaceuticals
$27,000,000
Series B Convertible Preferred StockCo-Placement Agent
September 2014
ATEA Pharmaceuticals
$10,000,000
Series A Convertible Preferred StockSole Placement Agent
May 2014